SI2203160T1 - Farmakološko dodatno zdravljenje, povezano s filtracijsko operacijo glavkoma - Google Patents

Farmakološko dodatno zdravljenje, povezano s filtracijsko operacijo glavkoma

Info

Publication number
SI2203160T1
SI2203160T1 SI200831060T SI200831060T SI2203160T1 SI 2203160 T1 SI2203160 T1 SI 2203160T1 SI 200831060 T SI200831060 T SI 200831060T SI 200831060 T SI200831060 T SI 200831060T SI 2203160 T1 SI2203160 T1 SI 2203160T1
Authority
SI
Slovenia
Prior art keywords
treatment associated
filtration surgery
glaucoma filtration
adjunctive treatment
pharmacological
Prior art date
Application number
SI200831060T
Other languages
English (en)
Inventor
Stephen P. Bartels
Original Assignee
Bausch & Lomb Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb Incorporated filed Critical Bausch & Lomb Incorporated
Publication of SI2203160T1 publication Critical patent/SI2203160T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200831060T 2007-09-27 2008-09-08 Farmakološko dodatno zdravljenje, povezano s filtracijsko operacijo glavkoma SI2203160T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97562007P 2007-09-27 2007-09-27
EP08799307.7A EP2203160B1 (en) 2007-09-27 2008-09-08 Pharmacological adjunctive treatment associated with glaucoma filtration surgery
PCT/US2008/075579 WO2009042377A1 (en) 2007-09-27 2008-09-08 Pharmacological adjunctive treatment associated with glaucoma filtration surgery

Publications (1)

Publication Number Publication Date
SI2203160T1 true SI2203160T1 (sl) 2013-11-29

Family

ID=40043043

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831060T SI2203160T1 (sl) 2007-09-27 2008-09-08 Farmakološko dodatno zdravljenje, povezano s filtracijsko operacijo glavkoma

Country Status (19)

Country Link
US (1) US20090087443A1 (sl)
EP (1) EP2203160B1 (sl)
JP (1) JP5249336B2 (sl)
KR (1) KR20100065166A (sl)
CN (1) CN101878026B (sl)
AU (1) AU2008305407B2 (sl)
BR (1) BRPI0817472A2 (sl)
CA (1) CA2699599C (sl)
CY (1) CY1114479T1 (sl)
DK (1) DK2203160T3 (sl)
ES (1) ES2424008T3 (sl)
HK (1) HK1145014A1 (sl)
HR (1) HRP20130817T1 (sl)
MX (1) MX2010003198A (sl)
PL (1) PL2203160T3 (sl)
PT (1) PT2203160E (sl)
SI (1) SI2203160T1 (sl)
TW (1) TWI366462B (sl)
WO (1) WO2009042377A1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010045463A2 (en) * 2008-10-15 2010-04-22 Government Of The United States As Represented By The Secretary Of The Army Clinical decision model
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
US10189773B2 (en) 2010-05-07 2019-01-29 Medicus Biosciences, Llc In-vivo gelling pharmaceutical pre-formulation
US10111985B2 (en) * 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US11083821B2 (en) 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
EP2846847B1 (en) 2012-05-11 2020-03-25 C.P. Medical Corporation Biocompatible hydrogel treatments for retinal detachment
JP2019511911A (ja) * 2016-02-17 2019-05-09 ノバルティス アーゲー Ｔｇｆベータ２抗体
WO2020152193A1 (en) 2019-01-22 2020-07-30 Akribes Biomedical Gmbh Selective glucocorticoid receptor modifiers for treating impaired skin wound healing

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
PT1034298E (pt) * 1997-12-05 2012-02-03 Scripps Research Inst Humanização de anticorpo murino
US6242196B1 (en) * 1997-12-11 2001-06-05 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
AU4713499A (en) * 1998-06-27 2000-01-17 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2276038T3 (es) * 2002-01-14 2007-06-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su obtencion, formulaciones farmaceuticas que los contienen y usos de los mismos.
US6903215B2 (en) * 2002-03-26 2005-06-07 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003230700A1 (en) * 2002-03-26 2003-10-13 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003297363A1 (en) * 2002-12-23 2004-07-22 Alcon, Inc. Use of cathepsin k inhibitors for the treatment of glaucoma
CA2512257A1 (en) * 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2006525011A (ja) * 2003-04-30 2006-11-09 ファイザー・プロダクツ・インク 白内障形成リスクに関するスクリーニング法
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US20050234091A1 (en) * 2004-03-22 2005-10-20 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US20050230128A1 (en) * 2004-04-06 2005-10-20 Smith Bret A Replaceable trench blade
US7417056B2 (en) * 2004-11-12 2008-08-26 Schering Ag 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
EP2056799B1 (en) * 2006-08-31 2013-07-31 Bausch & Lomb Incorporated Compositions and methods for treating or preventing glaucoma or progression thereof
MX2009002544A (es) * 2006-09-11 2009-03-20 Bausch & Lomb Composiciones y metodos para tratar, controlar, reducir, aminorar o evitar alergias.

Also Published As

Publication number Publication date
HK1145014A1 (en) 2011-03-25
US20090087443A1 (en) 2009-04-02
CY1114479T1 (el) 2016-10-05
EP2203160A1 (en) 2010-07-07
BRPI0817472A2 (pt) 2015-03-24
KR20100065166A (ko) 2010-06-15
AU2008305407A1 (en) 2009-04-02
MX2010003198A (es) 2010-04-01
JP2010540538A (ja) 2010-12-24
PL2203160T3 (pl) 2013-11-29
HRP20130817T1 (hr) 2013-09-30
CA2699599A1 (en) 2009-04-02
CA2699599C (en) 2012-10-23
TWI366462B (en) 2012-06-21
CN101878026B (zh) 2013-11-20
JP5249336B2 (ja) 2013-07-31
PT2203160E (pt) 2013-10-22
WO2009042377A1 (en) 2009-04-02
DK2203160T3 (da) 2013-09-02
AU2008305407B2 (en) 2012-12-20
EP2203160B1 (en) 2013-07-17
CN101878026A (zh) 2010-11-03
ES2424008T3 (es) 2013-09-26
TW200914014A (en) 2009-04-01

Similar Documents

Publication Publication Date Title
HRP20130817T1 (hr) Farmakološki adjunktivno lijeäśenje povezano s filtracijskom operacijom glaukoma
HK1219913A1 (zh) 眼放射外科
PT2526910E (pt) Dispositivo para tratamento de glaucoma
EP2172150A4 (en) CORNEAL OBSERVATION DEVICE
EP2020970A4 (en) TREATMENT OF THE EYE
EP2201422A4 (en) CROPPED OPTICAL FILTERS
EP2049713A4 (en) TISSUE REJECTION
GB0722592D0 (en) Surgeons headgear
GB0716605D0 (en) Skin antiseptics
PL2136748T3 (pl) Transplantacja rogówki
ZA200809327B (en) Ocular allergy treatments
GB0711342D0 (en) Well treatment
GB0707208D0 (en) Novel disease treatments
GB0716784D0 (en) Well treatment
IL205542A0 (en) Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
GB2451821B (en) Eye bath
IL205752A0 (en) Octahydroquinolizines for antidiabetic treatment
GB0805106D0 (en) Visor
GB0822101D0 (en) Ophthalmic irrigator
GB0808690D0 (en) Therapeutic use
GB0714430D0 (en) Disposable Eye Bath
GB0601091D0 (en) The Treatment Of Ocular Conditions
GB0700755D0 (en) The Treatment of ophthalmic diseases
GB0724838D0 (en) Effulent treatment
GB0710732D0 (en) Treatment